Brii Biosciences advances HBV study data alongside half year financial results
Biotechnology company Brii Biosciences released Phase 2b clinical data for its hepatitis B treatment strategy on 21 August 2026 alongside half year financial reporting
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.